These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7912495)

  • 1. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
    Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
    Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM; Goldenberg S; Gottesman MM; Hait WN
    Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
    Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M
    Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells.
    Kawai K; Kusano I; Ido M; Sakurai M; Shiraishi T; Yatani R
    Biochem Biophys Res Commun; 1994 Jan; 198(2):804-10. PubMed ID: 7905266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK; Chitnis MP
    Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of multidrug resistance by fluorescent dyes.
    Kessel D; Beck WT; Kukuruga D; Schulz V
    Cancer Res; 1991 Sep; 51(17):4665-70. PubMed ID: 1873811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A; Fuks Z; Gatt S; Glaubiger D
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring multidrug resistance using rhodamine 123.
    Kessel D
    Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin).
    Ganapathi R; Hercbergs A; Grabowski D; Ford J
    Cancer Res; 1993 Jul; 53(14):3262-5. PubMed ID: 8100737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
    Wilkoff LJ; Dulmadge EA
    J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic influences on doxorubicin-sensitive or -resistant P388 leukemia cells.
    D'Amico C; Crescimanno M; Armata MG; Leonardi V; Palazzoadriano M; D'Alessandro N
    Anticancer Res; 1992; 12(6B):2253-6. PubMed ID: 1338280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A; Cohen L; Glaubiger D
    Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine.
    Jaffrézou JP; Levade T; Chatelain P; Laurent G
    Cancer Res; 1992 Dec; 52(23):6440-6. PubMed ID: 1423291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide.
    Ido M; Sato K; Sakurai M; Inagaki M; Saitoh M; Watanabe M; Hidaka H
    Cancer Res; 1987 Jul; 47(13):3460-3. PubMed ID: 3581082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.
    Hyafil F; Vergely C; Du Vignaud P; Grand-Perret T
    Cancer Res; 1993 Oct; 53(19):4595-602. PubMed ID: 8402633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DNA biosynthesis by vincristine and pentoxifylline in murine P388 leukemia cells resistant to doxorubicin.
    Chitnis MP; Viladkar AB; Juvekar AS
    Neoplasma; 1990; 37(6):619-26. PubMed ID: 2274081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RS-33295-198: a novel, potent modulator of P-glycoprotein-mediated multidrug resistance.
    Slate DL; Bruno NA; Casey SM; Zutshi N; Garvin LJ; Wu H; Pfister JR
    Anticancer Res; 1995; 15(3):811-4. PubMed ID: 7645963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.